130 related articles for article (PubMed ID: 9266591)
1. Genotoxic properties of the newly synthesized antineoplastic agents amidox, didox and trimidox.
Miadoková E; Macáková K; Podstavková S; Vlcek D
Pharmazie; 1997 Jul; 52(7):540-4. PubMed ID: 9266591
[TBL] [Abstract][Full Text] [Related]
2. Iron binding capacity of didox (3,4 dihydroxybenzohydroxamic acid) and amidox (3,4 dihydroxybenzamidoxime) two inhibitors of the enzyme ribonucleotide reductase.
Fritzer-Szekeres M; Novotny L; Vachalkova A; Göbl R; Elford HL; Szekeres T
Adv Exp Med Biol; 1998; 431():599-604. PubMed ID: 9598136
[TBL] [Abstract][Full Text] [Related]
3. Iron binding capacity of didox (3,4-dihydroxybenzohydroxamic acid) and amidox (3,4-dihydroxybenzamidoxime) new inhibitors of the enzyme ribonucleotide reductase.
Fritzer-Szekeres M; Novotny L; Vachalkova A; Findenig G; Elford HL; Szekeres T
Life Sci; 1997; 61(22):2231-7. PubMed ID: 9393942
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
[TBL] [Abstract][Full Text] [Related]
5. Activation of caspases and induction of apoptosis by novel ribonucleotide reductase inhibitors amidox and didox.
Grusch M; Fritzer-Szekeres M; Fuhrmann G; Rosenberger G; Luxbacher C; Elford HL; Smid K; Peters GJ; Szekeres T; Krupitza G
Exp Hematol; 2001 May; 29(5):623-32. PubMed ID: 11376876
[TBL] [Abstract][Full Text] [Related]
6. DNA-protective activity of new ribonucleotide reductase inhibitors.
Rauko P; Romanova D; Miadokova E; Macakova K; Novotny L; Elford HL; Szekeres T
Anticancer Res; 1997; 17(5A):3437-40. PubMed ID: 9413183
[TBL] [Abstract][Full Text] [Related]
7. Organogermanium compounds as inhibitors of the activity of direct acting mutagens in Salmonella typhimurium.
Schimmer O; Eschelbach H; Breitinger DK; Grützner T; Wick H
Arzneimittelforschung; 1997 Dec; 47(12):1398-402. PubMed ID: 9450171
[TBL] [Abstract][Full Text] [Related]
8. Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells.
Myette MS; Elford HL; Chitambar CR
Cancer Lett; 1998 Jul; 129(2):199-204. PubMed ID: 9719462
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanisms of inhibition of L1210 cell growth by 3,4-dihydroxybenzohydroxamic acid and 3,4-dihydroxybenzamidoxime.
Tihan T; Elford HL; Cory JG
Adv Enzyme Regul; 1991; 31():71-83. PubMed ID: 1877400
[TBL] [Abstract][Full Text] [Related]
10. [The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].
Findenig G; Vielnascher E; Göbl R; Fritzer-Szekeres M; Szekeres T
Wien Klin Wochenschr; 1995; 107(22):694-7. PubMed ID: 8533431
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin.
Iyamu WE; Adunyah SE; Fasold H; Horiuchi K; Elford HL; Asakura T; Turner EA
Am J Hematol; 2000 Apr; 63(4):176-83. PubMed ID: 10706760
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of mutagenic activity of several antimalarial extracts from Eupatorium inulaefolium.
Pabón A; Lopera T; Carmona J; Blair S
Pharmazie; 2001 May; 56(5):412-4. PubMed ID: 11400559
[TBL] [Abstract][Full Text] [Related]
13. Effective use of ribonucleotide reductase inhibitors (Didox and Trimidox) alone or in combination with didanosine (ddI) to suppress disease progression and increase survival in murine acquired immunodeficiency syndrome (MAIDS).
Mayhew C; Oakley O; Piper J; Hughes NK; Phillips J; Birch NJ; Elford HL; Gallicchio VS
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1019-29. PubMed ID: 9449534
[TBL] [Abstract][Full Text] [Related]
14. Further examination of the effects of nitrosylation on Alternaria alternata mycotoxin mutagenicity in vitro.
Schrader TJ; Cherry W; Soper K; Langlois I
Mutat Res; 2006 Jul; 606(1-2):61-71. PubMed ID: 16698312
[TBL] [Abstract][Full Text] [Related]
15. The new inhibitors of ribonucleotide reductase--comparison of some physico-chemical properties.
Romanova D; Vachalkova A; Szekeres T; Elford HL; Novotny L
J Pharm Biomed Anal; 1997 Apr; 15(7):951-6. PubMed ID: 9160261
[TBL] [Abstract][Full Text] [Related]
16. Genotoxic evaluation of the organophosphorous pesticide temephos.
Aiub CA; Coelho EC; Sodré E; Pinto LF; Felzenszwalb I
Genet Mol Res; 2002 Jun; 1(2):159-66. PubMed ID: 14963843
[TBL] [Abstract][Full Text] [Related]
17. Genotoxic evaluation of extracts from Aplysina fulva, a Brazilian marine sponge.
Aiub C; Giannerini A; Ferreira F; Mazzei J; Stankevicins L; Lobo-Hajdu G; Guimarães P; Hajdu E; Felzenszwalb I
Mutat Res; 2006 Dec; 611(1-2):34-41. PubMed ID: 16987694
[TBL] [Abstract][Full Text] [Related]
18. Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
Mayhew CN; Sumpter R; Inayat M; Cibull M; Phillips JD; Elford HL; Gallicchio VS
Antiviral Res; 2005 Jan; 65(1):13-22. PubMed ID: 15652967
[TBL] [Abstract][Full Text] [Related]
19. Anthracene-9,10-diones as potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicity.
Venitt S; Crofton-Sleigh C; Agbandje M; Jenkins TC; Neidle S
J Med Chem; 1998 Sep; 41(19):3748-52. PubMed ID: 9733500
[TBL] [Abstract][Full Text] [Related]
20. Isolation and studies of the mutagenic activity of saponins in the Ames test.
Czeczot H; Rahden-Staroń I; Oleszek W; Jurzysta M
Acta Pol Pharm; 1994; 51(2):133-6. PubMed ID: 7779177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
